Medical Branch Alphabet – M
| S. No | Initialism | Full Form | Short Explanation | Practical Example |
|---|---|---|---|---|
| M001 | MRI | Magnetic Resonance Imaging | Imaging technique using magnetic fields | MRI of brain to detect stroke |
| M002 | MRA | Magnetic Resonance Angiography | Imaging of blood vessels using MRI | MRA for cerebral aneurysm |
| M003 | MCV | Mean Corpuscular Volume | Average red blood cell size | MCV elevated in macrocytic anemia |
| M004 | MCH | Mean Corpuscular Hemoglobin | Average hemoglobin per red blood cell | MCH low in iron deficiency anemia |
| M005 | MCHC | Mean Corpuscular Hemoglobin Concentration | Hemoglobin concentration per RBC | MCHC low in hypochromic anemia |
| M006 | MPV | Mean Platelet Volume | Average size of platelets | MPV elevated in thrombocytopenia |
| M007 | MI | Myocardial Infarction | Heart attack due to blocked coronary artery | MI treated with angioplasty |
| M008 | MVP | Mitral Valve Prolapse | Mitral valve bulging into left atrium | MVP monitored via echocardiography |
| M009 | MS | Multiple Sclerosis | Chronic autoimmune disease of CNS | MS treated with immunotherapy |
| M010 | MDS | Myelodysplastic Syndrome | Bone marrow disorder leading to abnormal blood cells | MDS monitored with bone marrow biopsy |
| M011 | MRI‑Rx | MRI Therapy Monitoring | Using MRI to monitor therapy response | MRI‑Rx: tumor size tracked |
| M012 | MRA‑Rx | MRA Therapy Monitoring | Monitoring vascular therapy | MRA‑Rx: aneurysm size tracked |
| M013 | MCV‑Rx | MCV Therapy Monitoring | Monitoring red blood cell size | MCV‑Rx: macrocytosis corrected |
| M014 | MCH‑Rx | MCH Therapy Monitoring | Monitoring hemoglobin per RBC | MCH‑Rx: iron therapy effect tracked |
| M015 | MCHC‑Rx | MCHC Therapy Monitoring | Monitoring hemoglobin concentration | MCHC‑Rx: hypochromia corrected |
| M016 | MPV‑Rx | MPV Therapy Monitoring | Monitoring platelet size | MPV‑Rx: platelet therapy effect tracked |
| M017 | MI‑Rx | Myocardial Infarction Therapy | Monitoring heart attack treatment | MI‑Rx: angioplasty follow-up |
| M018 | MVP‑Rx | Mitral Valve Prolapse Therapy | Monitoring MVP treatment | MVP‑Rx: echocardiography follow-up |
| M019 | MS‑Rx | Multiple Sclerosis Therapy | Monitoring MS therapy | MS‑Rx: immunotherapy response tracked |
| M020 | MDS‑Rx | Myelodysplastic Syndrome Therapy | Monitoring bone marrow therapy | MDS‑Rx: blood counts monitored |
| M021 | MRI‑Follow | MRI Follow-Up | Serial MRI scans to track disease | MRI‑Follow: tumor size monitored |
| M022 | MRA‑Follow | MRA Follow-Up | Serial vascular imaging | MRA‑Follow: aneurysm monitored |
| M023 | MCV‑Follow | MCV Follow-Up | Serial RBC size monitoring | MCV‑Follow: macrocytosis trend tracked |
| M024 | MCH‑Follow | MCH Follow-Up | Serial hemoglobin per RBC monitoring | MCH‑Follow: iron therapy response |
| M025 | MCHC‑Follow | MCHC Follow-Up | Serial hemoglobin concentration monitoring | MCHC‑Follow: hypochromia corrected |
| M026 | MPV‑Follow | MPV Follow-Up | Serial platelet size monitoring | MPV‑Follow: platelet therapy tracked |
| M027 | MI‑Follow | Myocardial Infarction Follow-Up | Monitoring post-MI patient | MI‑Follow: ECG and troponin checked |
| M028 | MVP‑Follow | Mitral Valve Prolapse Follow-Up | Monitoring MVP progression | MVP‑Follow: echo repeated yearly |
| M029 | MS‑Follow | Multiple Sclerosis Follow-Up | Monitoring MS progression | MS‑Follow: MRI brain lesions tracked |
| M030 | MDS‑Follow | Myelodysplastic Syndrome Follow-Up | Monitoring MDS progression | MDS‑Follow: CBC monitored weekly |
| M031 | MRI‑Trend | MRI Trend | Tracking changes via MRI | MRI‑Trend: tumor regression tracked |
| M032 | MRA‑Trend | MRA Trend | Tracking vascular changes | MRA‑Trend: vessel patency monitored |
| M033 | MCV‑Trend | MCV Trend | Tracking RBC size trends | MCV‑Trend: size normalizing after therapy |
| M034 | MCH‑Trend | MCH Trend | Tracking hemoglobin per RBC trend | MCH‑Trend: improved after iron therapy |
| M035 | MCHC‑Trend | MCHC Trend | Tracking hemoglobin concentration trend | MCHC‑Trend: hypochromia corrected |
| M036 | MPV‑Trend | MPV Trend | Tracking platelet size trend | MPV‑Trend: normalized after treatment |
| M037 | MI‑Trend | Myocardial Infarction Trend | Tracking heart function post-MI | MI‑Trend: ejection fraction improved |
| M038 | MVP‑Trend | Mitral Valve Prolapse Trend | Tracking MVP progression | MVP‑Trend: regurgitation stable |
| M039 | MS‑Trend | Multiple Sclerosis Trend | Tracking disease activity | MS‑Trend: lesions decreased |
| M040 | MDS‑Trend | Myelodysplastic Syndrome Trend | Tracking blood counts | MDS‑Trend: platelets stable |
| M041 | MRI‑Rec | MRI Recovery | Monitoring recovery via MRI | MRI‑Rec: tumor resolved |
| M042 | MRA‑Rec | MRA Recovery | Monitoring vascular recovery | MRA‑Rec: aneurysm size reduced |
| M043 | MCV‑Rec | MCV Recovery | RBC size normalization | MCV‑Rec: returned to normal range |
| M044 | MCH‑Rec | MCH Recovery | Hemoglobin per RBC normalized | MCH‑Rec: therapy effective |
| M045 | MCHC‑Rec | MCHC Recovery | Hemoglobin concentration normalized | MCHC‑Rec: hypochromia resolved |
| M046 | MPV‑Rec | MPV Recovery | Platelet size normalized | MPV‑Rec: post-therapy normal |
| M047 | MI‑Rec | Myocardial Infarction Recovery | Recovery monitoring post-MI | MI‑Rec: heart function improved |
| M048 | MVP‑Rec | Mitral Valve Prolapse Recovery | Recovery monitoring | MVP‑Rec: regurgitation improved |
| M049 | MS‑Rec | Multiple Sclerosis Recovery | Recovery monitoring | MS‑Rec: lesion load decreased |
| M050 | MDS‑Rec | Myelodysplastic Syndrome Recovery | Recovery monitoring | MDS‑Rec: blood counts stabilized |
| S. No | Initialism | Full Form | Short Explanation | Practical Example |
|---|---|---|---|---|
| M051 | MRI‑Comp | MRI Complication | Complications related to MRI procedure | MRI‑Comp: contrast reaction noted |
| M052 | MRA‑Comp | MRA Complication | Complications related to MRA | MRA‑Comp: allergic reaction to contrast |
| M053 | MCV‑Comp | MCV Complication | Abnormal RBC size complication | MCV‑Comp: persistent macrocytosis |
| M054 | MCH‑Comp | MCH Complication | Hemoglobin per RBC complication | MCH‑Comp: anemia unresolved |
| M055 | MCHC‑Comp | MCHC Complication | Hemoglobin concentration complication | MCHC‑Comp: hypochromia persists |
| M056 | MPV‑Comp | MPV Complication | Platelet size complication | MPV‑Comp: thrombocytopenia worsened |
| M057 | MI‑Comp | Myocardial Infarction Complication | Post-MI complications | MI‑Comp: heart failure developed |
| M058 | MVP‑Comp | Mitral Valve Prolapse Complication | Complications from MVP | MVP‑Comp: mitral regurgitation progressed |
| M059 | MS‑Comp | Multiple Sclerosis Complication | MS-related complications | MS‑Comp: new neurological deficit |
| M060 | MDS‑Comp | Myelodysplastic Syndrome Complication | Complications in MDS | MDS‑Comp: leukemic transformation |
| M061 | MRI‑Adj | MRI Adjustment | Adjusting MRI parameters | MRI‑Adj: slice thickness modified |
| M062 | MRA‑Adj | MRA Adjustment | Adjusting MRA parameters | MRA‑Adj: contrast dose adjusted |
| M063 | MCV‑Adj | MCV Adjustment | Adjusting RBC therapy | MCV‑Adj: vitamin B12 dose modified |
| M064 | MCH‑Adj | MCH Adjustment | Adjusting hemoglobin therapy | MCH‑Adj: iron therapy dose changed |
| M065 | MCHC‑Adj | MCHC Adjustment | Adjusting hemoglobin concentration therapy | MCHC‑Adj: supplement adjusted |
| M066 | MPV‑Adj | MPV Adjustment | Adjusting platelet therapy | MPV‑Adj: platelet transfusion planned |
| M067 | MI‑Adj | Myocardial Infarction Adjustment | Adjusting post-MI care | MI‑Adj: medication regimen modified |
| M068 | MVP‑Adj | Mitral Valve Prolapse Adjustment | Adjusting MVP therapy | MVP‑Adj: monitoring interval shortened |
| M069 | MS‑Adj | Multiple Sclerosis Adjustment | Adjusting MS therapy | MS‑Adj: immunotherapy dose modified |
| M070 | MDS‑Adj | Myelodysplastic Syndrome Adjustment | Adjusting MDS therapy | MDS‑Adj: transfusion schedule changed |
| M071 | MRI‑Rx‑Adj | MRI Therapy Adjustment | Adjusting therapy based on MRI | MRI‑Rx‑Adj: tumor-targeted therapy changed |
| M072 | MRA‑Rx‑Adj | MRA Therapy Adjustment | Adjusting therapy based on MRA | MRA‑Rx‑Adj: aneurysm treatment modified |
| M073 | MCV‑Rx‑Adj | MCV Therapy Adjustment | Adjusting RBC therapy | MCV‑Rx‑Adj: macrocytosis corrected |
| M074 | MCH‑Rx‑Adj | MCH Therapy Adjustment | Adjusting hemoglobin therapy | MCH‑Rx‑Adj: iron therapy modified |
| M075 | MCHC‑Rx‑Adj | MCHC Therapy Adjustment | Adjusting hemoglobin concentration therapy | MCHC‑Rx‑Adj: therapy optimized |
| M076 | MPV‑Rx‑Adj | MPV Therapy Adjustment | Adjusting platelet therapy | MPV‑Rx‑Adj: platelet transfusion changed |
| M077 | MI‑Rx‑Adj | Myocardial Infarction Therapy Adjustment | Adjusting post-MI therapy | MI‑Rx‑Adj: medication dose adjusted |
| M078 | MVP‑Rx‑Adj | MVP Therapy Adjustment | Adjusting MVP therapy | MVP‑Rx‑Adj: follow-up interval modified |
| M079 | MS‑Rx‑Adj | MS Therapy Adjustment | Adjusting MS therapy | MS‑Rx‑Adj: immunotherapy dose changed |
| M080 | MDS‑Rx‑Adj | MDS Therapy Adjustment | Adjusting MDS therapy | MDS‑Rx‑Adj: transfusion schedule optimized |
| M081 | MRI‑Follow‑Rx | MRI Follow-Up Therapy | Monitoring therapy with MRI | MRI‑Follow‑Rx: tumor size tracked |
| M082 | MRA‑Follow‑Rx | MRA Follow-Up Therapy | Monitoring therapy with MRA | MRA‑Follow‑Rx: aneurysm monitored |
| M083 | MCV‑Follow‑Rx | MCV Follow-Up Therapy | Monitoring RBC therapy | MCV‑Follow‑Rx: macrocytosis trend checked |
| M084 | MCH‑Follow‑Rx | MCH Follow-Up Therapy | Monitoring hemoglobin therapy | MCH‑Follow‑Rx: iron therapy effect monitored |
| M085 | MCHC‑Follow‑Rx | MCHC Follow-Up Therapy | Monitoring hemoglobin concentration therapy | MCHC‑Follow‑Rx: hypochromia corrected |
| M086 | MPV‑Follow‑Rx | MPV Follow-Up Therapy | Monitoring platelet therapy | MPV‑Follow‑Rx: platelet size trend checked |
| M087 | MI‑Follow‑Rx | MI Follow-Up Therapy | Monitoring post-MI therapy | MI‑Follow‑Rx: ECG and ejection fraction tracked |
| M088 | MVP‑Follow‑Rx | MVP Follow-Up Therapy | Monitoring MVP therapy | MVP‑Follow‑Rx: echo performed |
| M089 | MS‑Follow‑Rx | MS Follow-Up Therapy | Monitoring MS therapy | MS‑Follow‑Rx: lesion progression tracked |
| M090 | MDS‑Follow‑Rx | MDS Follow-Up Therapy | Monitoring MDS therapy | MDS‑Follow‑Rx: CBC monitored |
| M091 | MRI‑Trend‑Rx | MRI Therapy Trend | Tracking therapy via MRI | MRI‑Trend‑Rx: tumor reduction trend |
| M092 | MRA‑Trend‑Rx | MRA Therapy Trend | Tracking therapy via MRA | MRA‑Trend‑Rx: vessel patency trend |
| M093 | MCV‑Trend‑Rx | RBC Therapy Trend | Tracking RBC therapy | MCV‑Trend‑Rx: macrocytosis improvement |
| M094 | MCH‑Trend‑Rx | Hemoglobin Therapy Trend | Tracking hemoglobin therapy | MCH‑Trend‑Rx: improvement noted |
| M095 | MCHC‑Trend‑Rx | Hemoglobin Concentration Trend | Tracking therapy | MCHC‑Trend‑Rx: normalized |
| M096 | MPV‑Trend‑Rx | Platelet Therapy Trend | Tracking platelet therapy | MPV‑Trend‑Rx: platelet size normalized |
| M097 | MI‑Trend‑Rx | Myocardial Infarction Trend | Tracking post-MI recovery | MI‑Trend‑Rx: ejection fraction improving |
| M098 | MVP‑Trend‑Rx | MVP Trend | Tracking MVP progression | MVP‑Trend‑Rx: regurgitation stable |
| M099 | MS‑Trend‑Rx | MS Trend | Tracking MS therapy | MS‑Trend‑Rx: lesion load decreased |
| M100 | MDS‑Trend‑Rx | MDS Trend | Tracking MDS therapy | MDS‑Trend‑Rx: platelet counts stable |
| S. No | Initialism | Full Form | Short Explanation | Practical Example |
|---|---|---|---|---|
| M101 | MRI‑Rec‑Rx | MRI Recovery Therapy | Monitoring recovery using MRI | MRI‑Rec‑Rx: tumor resolved |
| M102 | MRA‑Rec‑Rx | MRA Recovery Therapy | Monitoring vascular recovery | MRA‑Rec‑Rx: aneurysm reduced |
| M103 | MCV‑Rec‑Rx | RBC Recovery Therapy | Normalizing RBC size | MCV‑Rec‑Rx: macrocytosis corrected |
| M104 | MCH‑Rec‑Rx | Hemoglobin Recovery Therapy | Normalizing hemoglobin per RBC | MCH‑Rec‑Rx: anemia corrected |
| M105 | MCHC‑Rec‑Rx | Hemoglobin Concentration Recovery | Normalizing hemoglobin concentration | MCHC‑Rec‑Rx: hypochromia resolved |
| M106 | MPV‑Rec‑Rx | Platelet Recovery Therapy | Normalizing platelet size | MPV‑Rec‑Rx: platelet counts normalized |
| M107 | MI‑Rec‑Rx | Myocardial Infarction Recovery Therapy | Post-MI recovery monitoring | MI‑Rec‑Rx: heart function improved |
| M108 | MVP‑Rec‑Rx | Mitral Valve Prolapse Recovery Therapy | Recovery monitoring | MVP‑Rec‑Rx: regurgitation reduced |
| M109 | MS‑Rec‑Rx | Multiple Sclerosis Recovery Therapy | Recovery monitoring | MS‑Rec‑Rx: lesion load decreased |
| M110 | MDS‑Rec‑Rx | Myelodysplastic Syndrome Recovery Therapy | Recovery monitoring | MDS‑Rec‑Rx: blood counts stable |
| M111 | MRI‑Comp‑Rx | MRI Complication Therapy | Managing MRI-related complications | MRI‑Comp‑Rx: contrast reaction treated |
| M112 | MRA‑Comp‑Rx | MRA Complication Therapy | Managing MRA complications | MRA‑Comp‑Rx: allergic reaction managed |
| M113 | MCV‑Comp‑Rx | RBC Complication Therapy | Managing RBC therapy complications | MCV‑Comp‑Rx: macrocytosis persisted |
| M114 | MCH‑Comp‑Rx | Hemoglobin Complication Therapy | Managing hemoglobin therapy complications | MCH‑Comp‑Rx: anemia persisted |
| M115 | MCHC‑Comp‑Rx | Hemoglobin Concentration Complication | Managing hemoglobin concentration complications | MCHC‑Comp‑Rx: hypochromia persisted |
| M116 | MPV‑Comp‑Rx | Platelet Complication Therapy | Managing platelet therapy complications | MPV‑Comp‑Rx: thrombocytopenia worsened |
| M117 | MI‑Comp‑Rx | Myocardial Infarction Complication Therapy | Managing post-MI complications | MI‑Comp‑Rx: heart failure treated |
| M118 | MVP‑Comp‑Rx | MVP Complication Therapy | Managing MVP complications | MVP‑Comp‑Rx: regurgitation managed |
| M119 | MS‑Comp‑Rx | Multiple Sclerosis Complication Therapy | Managing MS complications | MS‑Comp‑Rx: relapse treated |
| M120 | MDS‑Comp‑Rx | Myelodysplastic Syndrome Complication Therapy | Managing MDS complications | MDS‑Comp‑Rx: leukemic transformation treated |
| M121 | MRI‑Check | MRI Check | Single MRI assessment | MRI‑Check: brain tumor evaluated |
| M122 | MRA‑Check | MRA Check | Single MRA assessment | MRA‑Check: aneurysm evaluated |
| M123 | MCV‑Check | RBC Check | Single RBC assessment | MCV‑Check: macrocytosis measured |
| M124 | MCH‑Check | Hemoglobin Check | Single hemoglobin assessment | MCH‑Check: iron therapy effect checked |
| M125 | MCHC‑Check | Hemoglobin Concentration Check | Single check of hemoglobin concentration | MCHC‑Check: hypochromia measured |
| M126 | MPV‑Check | Platelet Check | Single platelet assessment | MPV‑Check: platelet size checked |
| M127 | MI‑Check | Myocardial Infarction Check | Single post-MI assessment | MI‑Check: ECG and biomarkers checked |
| M128 | MVP‑Check | MVP Check | Single MVP assessment | MVP‑Check: echocardiography performed |
| M129 | MS‑Check | MS Check | Single MS assessment | MS‑Check: neurological exam performed |
| M130 | MDS‑Check | MDS Check | Single MDS assessment | MDS‑Check: CBC reviewed |
| M131 | MRI‑Eval | MRI Evaluation | Clinical assessment via MRI | MRI‑Eval: tumor size measured |
| M132 | MRA‑Eval | MRA Evaluation | Clinical assessment via MRA | MRA‑Eval: vessel patency evaluated |
| M133 | MCV‑Eval | RBC Evaluation | Assessing RBC size clinically | MCV‑Eval: macrocytosis assessed |
| M134 | MCH‑Eval | Hemoglobin Evaluation | Assessing hemoglobin clinically | MCH‑Eval: anemia evaluated |
| M135 | MCHC‑Eval | Hemoglobin Concentration Evaluation | Assessing hemoglobin concentration | MCHC‑Eval: hypochromia evaluated |
| M136 | MPV‑Eval | Platelet Evaluation | Assessing platelet status | MPV‑Eval: thrombocytopenia assessed |
| M137 | MI‑Eval | Myocardial Infarction Evaluation | Post-MI clinical assessment | MI‑Eval: ECG and echo assessed |
| M138 | MVP‑Eval | MVP Evaluation | Assessing MVP severity | MVP‑Eval: regurgitation assessed |
| M139 | MS‑Eval | MS Evaluation | Assessing MS progression | MS‑Eval: neurological deficits tracked |
| M140 | MDS‑Eval | MDS Evaluation | Assessing MDS progression | MDS‑Eval: blood counts analyzed |
| M141 | MRI‑Plan | MRI Therapy Plan | Planning therapy based on MRI | MRI‑Plan: tumor-targeted therapy designed |
| M142 | MRA‑Plan | MRA Therapy Plan | Planning therapy based on MRA | MRA‑Plan: aneurysm intervention planned |
| M143 | MCV‑Plan | RBC Therapy Plan | Planning RBC-related therapy | MCV‑Plan: vitamin B12 scheduled |
| M144 | MCH‑Plan | Hemoglobin Therapy Plan | Planning hemoglobin therapy | MCH‑Plan: iron supplements prescribed |
| M145 | MCHC‑Plan | Hemoglobin Concentration Plan | Planning therapy | MCHC‑Plan: supplement regimen scheduled |
| M146 | MPV‑Plan | Platelet Therapy Plan | Planning platelet therapy | MPV‑Plan: transfusion planned |
| M147 | MI‑Plan | Myocardial Infarction Plan | Planning post-MI care | MI‑Plan: medications scheduled |
| M148 | MVP‑Plan | MVP Therapy Plan | Planning MVP management | MVP‑Plan: follow-up interval scheduled |
| M149 | MS‑Plan | MS Therapy Plan | Planning MS management | MS‑Plan: immunotherapy regimen designed |
| M150 | MDS‑Plan | MDS Therapy Plan | Planning MDS management | MDS‑Plan: transfusions scheduled |
| M151 | MRI‑Report | MRI Report | Documenting MRI findings | MRI‑Report: tumor dimensions recorded |
| M152 | MRA‑Report | MRA Report | Documenting MRA findings | MRA‑Report: aneurysm size recorded |
| M153 | MCV‑Report | RBC Report | Documenting RBC status | MCV‑Report: macrocytosis documented |
| M154 | MCH‑Report | Hemoglobin Report | Documenting hemoglobin status | MCH‑Report: anemia noted |
| M155 | MCHC‑Report | Hemoglobin Concentration Report | Documenting hemoglobin concentration | MCHC‑Report: hypochromia documented |
| M156 | MPV‑Report | Platelet Report | Documenting platelet status | MPV‑Report: thrombocytopenia documented |
| M157 | MI‑Report | Myocardial Infarction Report | Documenting post-MI findings | MI‑Report: ECG and troponin recorded |
| M158 | MVP‑Report | MVP Report | Documenting MVP status | MVP‑Report: echocardiography recorded |
| M159 | MS‑Report | MS Report | Documenting MS findings | MS‑Report: MRI lesions recorded |
| M160 | MDS‑Report | MDS Report | Documenting MDS status | MDS‑Report: CBC results recorded |
| M161 | MRI‑Summary | MRI Summary | Summarizing MRI findings | MRI‑Summary: tumor trend summarized |
| M162 | MRA‑Summary | MRA Summary | Summarizing MRA findings | MRA‑Summary: vessel patency summarized |
| M163 | MCV‑Summary | RBC Summary | Summarizing RBC status | MCV‑Summary: macrocytosis trend |
| M164 | MCH‑Summary | Hemoglobin Summary | Summarizing hemoglobin | MCH‑Summary: anemia trend |
| M165 | MCHC‑Summary | Hemoglobin Concentration Summary | Summarizing hemoglobin concentration | MCHC‑Summary: hypochromia trend |
| M166 | MPV‑Summary | Platelet Summary | Summarizing platelet status | MPV‑Summary: thrombocytopenia trend |
| M167 | MI‑Summary | Myocardial Infarction Summary | Summarizing post-MI findings | MI‑Summary: recovery trend |
| M168 | MVP‑Summary | MVP Summary | Summarizing MVP status | MVP‑Summary: regurgitation trend |
| M169 | MS‑Summary | MS Summary | Summarizing MS therapy | MS‑Summary: lesion trend |
| M170 | MDS‑Summary | MDS Summary | Summarizing MDS therapy | MDS‑Summary: CBC trend |
| M171 | MRI‑Data | MRI Data | Collecting MRI findings | MRI‑Data: tumor measurements |
| M172 | MRA‑Data | MRA Data | Collecting MRA findings | MRA‑Data: vessel diameter |
| M173 | MCV‑Data | RBC Data | Collecting RBC lab data | MCV‑Data: cell volume |
| M174 | MCH‑Data | Hemoglobin Data | Collecting hemoglobin data | MCH‑Data: Hb per RBC |
| M175 | MCHC‑Data | Hemoglobin Concentration Data | Collecting Hb concentration data | MCHC‑Data: lab values recorded |
| M176 | MPV‑Data | Platelet Data | Collecting platelet lab data | MPV‑Data: platelet size measured |
| M177 | MI‑Data | Myocardial Infarction Data | Collecting post-MI clinical data | MI‑Data: ECG, troponin |
| M178 | MVP‑Data | MVP Data | Collecting MVP clinical data | MVP‑Data: echo measurements |
| M179 | MS‑Data | MS Data | Collecting MS clinical data | MS‑Data: lesion load |
| M180 | MDS‑Data | MDS Data | Collecting MDS lab data | MDS‑Data: CBC values |
| M181 | MRI‑Check‑Rx | MRI Therapy Check | Checking therapy effect via MRI | MRI‑Check‑Rx: tumor response evaluated |
| M182 | MRA‑Check‑Rx | MRA Therapy Check | Checking therapy effect via MRA | MRA‑Check‑Rx: aneurysm progress evaluated |
| M183 | MCV‑Check‑Rx | RBC Therapy Check | Checking RBC therapy effect | MCV‑Check‑Rx: macrocytosis improving |
| M184 | MCH‑Check‑Rx | Hemoglobin Therapy Check | Checking hemoglobin therapy effect | MCH‑Check‑Rx: anemia improving |
| M185 | MCHC‑Check‑Rx | Hemoglobin Concentration Check | Checking Hb concentration therapy effect | MCHC‑Check‑Rx: hypochromia improving |
| M186 | MPV‑Check‑Rx | Platelet Therapy Check | Checking platelet therapy effect | MPV‑Check‑Rx: platelet count normalizing |
| M187 | MI‑Check‑Rx | MI Therapy Check | Checking post-MI therapy effect | MI‑Check‑Rx: ECG improving |
| M188 | MVP‑Check‑Rx | MVP Therapy Check | Checking MVP therapy effect | MVP‑Check‑Rx: regurgitation reduced |
| M189 | MS‑Check‑Rx | MS Therapy Check | Checking MS therapy effect | MS‑Check‑Rx: lesion progression monitored |
| M190 | MDS‑Check‑Rx | MDS Therapy Check | Checking MDS therapy effect | MDS‑Check‑Rx: CBC monitored |
| M191 | MRI‑Monitor‑Rx | MRI Therapy Monitoring | Serial MRI monitoring | MRI‑Monitor‑Rx: tumor regression tracked |
| M192 | MRA‑Monitor‑Rx | MRA Therapy Monitoring | Serial MRA monitoring | MRA‑Monitor‑Rx: vessel patency tracked |
| M193 | MCV‑Monitor‑Rx | RBC Therapy Monitoring | Serial RBC monitoring | MCV‑Monitor‑Rx: cell volume normalized |
| M194 | MCH‑Monitor‑Rx | Hemoglobin Therapy Monitoring | Serial hemoglobin monitoring | MCH‑Monitor‑Rx: Hb normalized |
| M195 | MCHC‑Monitor‑Rx | Hemoglobin Concentration Monitoring | Serial Hb concentration monitoring | MCHC‑Monitor‑Rx: hypochromia corrected |
| M196 | MPV‑Monitor‑Rx | Platelet Therapy Monitoring | Serial platelet monitoring | MPV‑Monitor‑Rx: platelet counts normalized |
| M197 | MI‑Monitor‑Rx | MI Therapy Monitoring | Serial post-MI monitoring | MI‑Monitor‑Rx: ECG trend observed |
| M198 | MVP‑Monitor‑Rx | MVP Therapy Monitoring | Serial MVP monitoring | MVP‑Monitor‑Rx: echo trend tracked |
| M199 | MS‑Monitor‑Rx | MS Therapy Monitoring | Serial MS monitoring | MS‑Monitor‑Rx: lesion trend tracked |
| M200 | MDS‑Monitor‑Rx | MDS Therapy Monitoring | Serial MDS monitoring | MDS‑Monitor‑Rx: CBC trend tracked |



